McIntyre, DJ; Robinson, SP; Howe, FA; Griffiths, JR; Ryan, AJ; Blakey, DC; Peers, IS; Waterton, JC
(2004)
Single dose of the antivascular agent, ZD6126 (N-acetylcoichinol-O-phosphate), reduces perfusion for at least 96 hours in the GH3 prolactinoma rat tumor model.
NEOPLASIA, 6 (2).
150 - 157 (8).
ISSN 1522-8002
https://doi.org/10.1593/neo.03247
SGUL Authors: Howe, Franklyn Arron
Full text not available from this repository.
| Item Type: |
Article
|
| Additional Information: |
PubMed ID: 15140404 |
| Keywords: |
Animals, Disease Models, Animal, Magnetic Resonance Imaging, Necrosis, Neovascularization, Pathologic, Organophosphorus Compounds, Pituitary Neoplasms, Prolactinoma, Rats, Rats, Inbred WF, Regional Blood Flow, Science & Technology, Life Sciences & Biomedicine, Oncology, ZD6126, vascular targeting, therapy, cancer, MRI, VASCULAR-TARGETING AGENT, BLOOD-FLOW, THERAPY, GROWTH, ZD6126, vascular targeting, therapy, cancer, MRI |
| SGUL Research Institute / Research Centre: |
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Neuroscience (INCCNS) |
| Journal or Publication Title: |
NEOPLASIA |
| ISSN: |
1522-8002 |
| Related URLs: |
|
| Dates: |
| Date | Event |
|---|
| 1 March 2004 | Published |
|
| Web of Science ID: |
WOS:000221133400007 |
  |
Download EPMC Full text (PDF)
|
|
Download EPMC Full text (HTML)
|
| URI: |
https://openaccess.sgul.ac.uk/id/eprint/146 |
| Publisher's version: |
https://doi.org/10.1593/neo.03247 |
Actions (login required)
 |
Edit Item |
